Hengrui Medicine (600276.SH) plans to spend 1 billion to 2 billion RMB to repurchase shares at a repurchase price not exceeding 90.85 yuan per share.

Wisdom Finance APP News, Hansoh Pharmaceutical (600276.SH) announced that the company plans to repurchase A-shares for the A-share employee stock ownership plan; plans to use funds totaling no less than 1 billion yuan, not exceeding 2 billion yuan; the repurchase price does not exceed 90.85 yuan per share; the repurchase period shall not exceed 12 months from the date on which the repurchase plan is approved by the board of directors of the company.